227 related articles for article (PubMed ID: 9406015)
1. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor.
Wiener EC; Konda S; Shadron A; Brechbiel M; Gansow O
Invest Radiol; 1997 Dec; 32(12):748-54. PubMed ID: 9406015
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts.
Konda SD; Wang S; Brechbiel M; Wiener EC
Invest Radiol; 2002 Apr; 37(4):199-204. PubMed ID: 11923642
[TBL] [Abstract][Full Text] [Related]
3. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts.
Konda SD; Aref M; Wang S; Brechbiel M; Wiener EC
MAGMA; 2001 May; 12(2-3):104-13. PubMed ID: 11390265
[TBL] [Abstract][Full Text] [Related]
4. Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress.
Konda SD; Aref M; Brechbiel M; Wiener EC
Invest Radiol; 2000 Jan; 35(1):50-7. PubMed ID: 10639036
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced folate-receptor-targeted MR imaging using a Gd-loaded PEG-dendrimer-folate conjugate in a mouse xenograft tumor model.
Chen WT; Thirumalai D; Shih TT; Chen RC; Tu SY; Lin CI; Yang PC
Mol Imaging Biol; 2010 Apr; 12(2):145-54. PubMed ID: 19636639
[TBL] [Abstract][Full Text] [Related]
6. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
Choi H; Choi SR; Zhou R; Kung HF; Chen IW
Acad Radiol; 2004 Sep; 11(9):996-1004. PubMed ID: 15350580
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting.
Choi Y; Thomas T; Kotlyar A; Islam MT; Baker JR
Chem Biol; 2005 Jan; 12(1):35-43. PubMed ID: 15664513
[TBL] [Abstract][Full Text] [Related]
8. Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.
Swanson SD; Kukowska-Latallo JF; Patri AK; Chen C; Ge S; Cao Z; Kotlyar A; East AT; Baker JR
Int J Nanomedicine; 2008; 3(2):201-10. PubMed ID: 18686779
[TBL] [Abstract][Full Text] [Related]
9. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
10. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
Myc A; Douce TB; Ahuja N; Kotlyar A; Kukowska-Latallo J; Thomas TP; Baker JR
Anticancer Drugs; 2008 Feb; 19(2):143-9. PubMed ID: 18176110
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.
Mullen DG; McNerny DQ; Desai A; Cheng XM; Dimaggio SC; Kotlyar A; Zhong Y; Qin S; Kelly CV; Thomas TP; Majoros I; Orr BG; Baker JR; Banaszak Holl MM
Bioconjug Chem; 2011 Apr; 22(4):679-89. PubMed ID: 21425790
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer.
Choi Y; Baker JR
Cell Cycle; 2005 May; 4(5):669-71. PubMed ID: 15846063
[TBL] [Abstract][Full Text] [Related]
13. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor.
Quintana A; Raczka E; Piehler L; Lee I; Myc A; Majoros I; Patri AK; Thomas T; Mulé J; Baker JR
Pharm Res; 2002 Sep; 19(9):1310-6. PubMed ID: 12403067
[TBL] [Abstract][Full Text] [Related]
14. Tumor imaging using P866, a high-relaxivity gadolinium chelate designed for folate receptor targeting.
Corot C; Robert P; Lancelot E; Prigent P; Ballet S; Guilbert I; Raynaud JS; Raynal I; Port M
Magn Reson Med; 2008 Dec; 60(6):1337-46. PubMed ID: 19025883
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent.
Cheng Z; Thorek DL; Tsourkas A
Angew Chem Int Ed Engl; 2010; 49(2):346-50. PubMed ID: 19967688
[No Abstract] [Full Text] [Related]
16. Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells.
Shi X; Wang SH; Lee I; Shen M; Baker JR
Biopolymers; 2009 Nov; 91(11):936-42. PubMed ID: 19603491
[TBL] [Abstract][Full Text] [Related]
17. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
Shukla S; Wu G; Chatterjee M; Yang W; Sekido M; Diop LA; Müller R; Sudimack JJ; Lee RJ; Barth RF; Tjarks W
Bioconjug Chem; 2003; 14(1):158-67. PubMed ID: 12526705
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
